$73.07 -0.29 (%) Gilead Sciences Inc - NASDAQ

Jan. 13, 2017 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Calithera Pharma In Focus, Part 3 - Arginase Inhibitor And Acquisition Target

    TalkMarkets | Jan. 9, 2017 | 07:51AM EST
  2. Widespread Buying

    TalkMarkets | Jan. 6, 2017 | 15:46PM EST
  3. 5 Companies For Enterprising Investors Near 52 Week Lows – January 2017

    TalkMarkets | Jan. 4, 2017 | 18:01PM EST
  4. 10 Low PE Stock Picks For The Enterprising Investor – January 2017

    TalkMarkets | Jan. 3, 2017 | 11:33AM EST
  5. 10 Low PE Stock Picks For The Enterprising Investor

    TalkMarkets | Jan. 3, 2017 | 11:33AM EST
  6. Gilead Is A Hail Mary: 3 Better Stocks To Consider

    TalkMarkets | Dec. 23, 2016 | 12:21PM EST
  7. 10 Undervalued Stocks for the Enterprising Investor – December 2016

    TalkMarkets | Dec. 22, 2016 | 12:00PM EST
  8. 10 Undervalued Stocks for the Enterprising Investor

    TalkMarkets | Dec. 22, 2016 | 12:00PM EST
  9. Conatus Soars On Novartis Deal, Early FDA Nod For Clovis Drug

    TalkMarkets | Dec. 21, 2016 | 10:55AM EST
  10. Gilead Buying Alexion Tops Piper's Potential Events In 2017

    TalkMarkets | Dec. 21, 2016 | 08:36AM EST
  11. Biotechs Fade Again In Late Day Sell-Off

    TalkMarkets | Dec. 19, 2016 | 20:51PM EST
  12. Conatus Pharma Skyrockets On Novartis NASH Liver Drug Licensing Deal

    Investors Business Daily | Dec. 19, 2016 | 17:52PM EST
  13. Incyte Could Step Onto Auction Block With Strong Jakafi Sales: RBC

    Investors Business Daily | Dec. 19, 2016 | 11:58AM EST
  14. Can GILD Stock Make A Comeback In 2017?

    TalkMarkets | Dec. 16, 2016 | 14:20PM EST
  15. Stocks Mixed, Mostly Unchanged; Apple Unfazed By Piper Jaffray Note

    Investors Business Daily | Dec. 16, 2016 | 12:09PM EST
  16. Morning Call For Friday, Dec. 16

    TalkMarkets | Dec. 16, 2016 | 09:47AM EST
  17. Gilead Must Pay Merck $2.5 Billion In Hep C Patent Fight; Agios Stock Anemic

    Investors Business Daily | Dec. 15, 2016 | 18:26PM EST
  18. Biotechs Mixed Hurt By Alexion And Ophthotech

    TalkMarkets | Dec. 12, 2016 | 23:03PM EST
  19. Merck Leads 212 Stocks Going Ex-Dividend This Week

    Dividend.com | Dec. 12, 2016 | 13:00PM EST
  20. 10 Stocks for Using A Benjamin Graham Value Investing Strategy – December 2016

    TalkMarkets | Dec. 9, 2016 | 17:35PM EST
  21. 5 Companies for Enterprising Investors Near 52 Week Lows – December 2016

    TalkMarkets | Dec. 5, 2016 | 10:10AM EST
  22. 10 Low PE Stock Picks For The Enterprising Investor – Dec 2016

    TalkMarkets | Dec. 3, 2016 | 18:17PM EST
  23. Market Reversal In Biotech But Healthcare Stocks Are Still Muddled

    TalkMarkets | Nov. 29, 2016 | 22:56PM EST
  24. GILD Stock: The Rally In Gilead Sciences Inc. Stock Is Just Getting Started

    TalkMarkets | Nov. 21, 2016 | 11:59AM EST
  25. GILD Stock: The Rally In Gilead Sciences Inc. Is Just Getting Started

    TalkMarkets | Nov. 21, 2016 | 11:59AM EST
  26. Gilead Sciences: Dirt Cheap with Lots of Growth Potential

    TalkMarkets | Nov. 17, 2016 | 13:36PM EST
  27. Incyte Shares Jump After Gilead Misses With Myelofibrosis Competitor

    TalkMarkets | Nov. 16, 2016 | 21:30PM EST
  28. Sell These 5 Stocks Now Before It’s Too Late - Wednesday, November 16

    TalkMarkets | Nov. 16, 2016 | 17:15PM EST
  29. Biotech Stocks Soar on Election Results, Gilead HBV Drug Approved

    TalkMarkets | Nov. 16, 2016 | 15:30PM EST
  30. US Stock Charts And Ideas

    TalkMarkets | Nov. 15, 2016 | 15:26PM EST
  31. Dividend Analysis Shows Gilead Is Undervalued

    TalkMarkets | Nov. 15, 2016 | 10:24AM EST
  32. Rayno Biobeat #3…Trump Biotech Rally Leads Market Up

    TalkMarkets | Nov. 9, 2016 | 23:23PM EST
  33. Street Check: Leerink Hits Mark With Early Warning On Alexion Troubles

    TalkMarkets | Nov. 9, 2016 | 21:50PM EST
  34. Rayno Biobeat #2…Good Value in Large Cap Biopharmaceuticals

    TalkMarkets | Nov. 7, 2016 | 10:20AM EST
  35. Before The Move: Stocks To Own If Trump Wins

    TalkMarkets | Nov. 6, 2016 | 16:47PM EST
  36. Pricing Issues Continue To Weigh On The Pharma Sector

    TalkMarkets | Nov. 5, 2016 | 20:01PM EST
  37. Gilead Misses Q3 Earnings, Reiterates 2016 Guidance

    TalkMarkets | Nov. 1, 2016 | 21:40PM EST
  38. 5 Stocks to Watch After the Market Closes Today - 11/1/2016

    TalkMarkets | Nov. 1, 2016 | 10:06AM EST
  39. Gilead is Sending a Sell Signal Ahead of its Earnings Report

    TalkMarkets | Nov. 1, 2016 | 09:14AM EST
  40. Biotech Meltdown: Financial Metrics Offer Few Clues For What is Next

    TalkMarkets | Nov. 1, 2016 | 06:52AM EST
  41. 5 Stocks To Watch This Week - October 31, 2016

    TalkMarkets | Oct. 31, 2016 | 12:17PM EST
  42. Gilead Sciences, Inc.: Why You Should Go Long On Gilead Stock?

    TalkMarkets | Oct. 28, 2016 | 15:30PM EST
  43. Biotech Bear Market Looking For Relief From Q3 Large Cap Growth

    TalkMarkets | Oct. 26, 2016 | 20:45PM EST
  44. Biotech Stock Roundup: Clinical Holds Hit Inovio & Aduro, Vertex Q3 Results Miss Estimates

    TalkMarkets | Oct. 26, 2016 | 14:15PM EST
  45. Weighing the Week Ahead: When Will the Trading Range Be Broken?

    TalkMarkets | Oct. 23, 2016 | 03:24AM EST
  46. Jefferies Sees 'Attractive Buying Opportunities' In Biotech

    TalkMarkets | Oct. 18, 2016 | 10:16AM EST
  47. Can-Fite An Emerging NASH Play With CF102

    TalkMarkets | Oct. 13, 2016 | 09:10AM EST
  48. Biotech Stocks Recovering From Last Week’s Free Fall

    TalkMarkets | Oct. 5, 2016 | 23:06PM EST
  49. Rayno 2016 Life Science Portfolio Update

    TalkMarkets | Sep. 29, 2016 | 20:14PM EST
  50. Gilead 'Paralyzed' On Likely Hepatitis C Share Loss To AbbVie, Merck

    IBD | Sep. 27, 2016 | 15:28PM EST
Trading Center